GlassScriptPhysician profile
Christopher J Goulet
NPI 1023085180
$2,231.30
in general payments reported to CMS, 2019-2025
15 companies · $686 in 2025
The $686 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $120 · 2021: $45.18 · 2022: $162 · 2023: $656 · 2024: $563 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,337.43 | 2020-2025 | |
| Celgene Corporation | $251.50 | 2022-2024 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $95.60 | 2023-2025 | Entyvio, Eohilia |
| Intercept Pharmaceuticals, INC. | $81.43 | 2020 | |
| Genzyme Corporation | $65.25 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $64.72 | 2022-2025 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.48 | 2024 | Xifaxan |
| Madrigal Pharmaceuticals | $56.06 | 2025 | Rezdiffra |
| Janssen Biotech, INC. | $41.95 | 2023-2024 | Stelara, Simponi, Simponi Aria |
| Lilly USA, LLC | $36.98 | 2023-2024 | Omvoh |
| Gilead Sciences, INC. | $35.30 | 2020-2025 | |
| Aimmune Therapeutics, INC. | $31.88 | 2024-2025 | Vowst |
| Pfizer INC. | $31.37 | 2022-2025 | |
| Ardelyx, INC. | $29.84 | 2023 | Ibsrela |
| Boston Scientific Corporation | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Goulet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.